CD274 and neoplasm: The combination of DC vaccine and PD-L1 inhibitor resulted in longer overall survival, smaller tumor size, and higher tumor cell apoptosis rate in mice. The combination of DC vaccine and PD-L1 inhibitor may have broad prospects as a new therapeutic strategy for HCC.